Virus News and Research

Latest Virus News and Research

How does the non-structural protein 1 affect COVID-19 pathogenicity?

How does the non-structural protein 1 affect COVID-19 pathogenicity?

20 Mar 2022
Cov2clusters: Novel method for producing stable genomic clusters of SARS-CoV-2 cases

Cov2clusters: Novel method for producing stable genomic clusters of SARS-CoV-2 cases

20 Mar 2022
Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

20 Mar 2022
Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

20 Mar 2022
Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

20 Mar 2022
Natural circulating antibodies last for at least seven months in children infected with COVID-19

Natural circulating antibodies last for at least seven months in children infected with COVID-19

18 Mar 2022
Understanding how coronavirus, RS virus and rhinovirus affect children

Understanding how coronavirus, RS virus and rhinovirus affect children

18 Mar 2022
New study tracks food insecurity during the COVID-19 pandemic

New study tracks food insecurity during the COVID-19 pandemic

18 Mar 2022
Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

18 Mar 2022
SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

18 Mar 2022
Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

Covalent protein nanobodies for neutralizing SARS-CoV-2 and its variants

18 Mar 2022
Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

18 Mar 2022
Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

18 Mar 2022
Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

Neutrophils found to initiate COVID-19-associated olfactory epithelial damage in hamsters

18 Mar 2022
New virus-based approach for measuring variations in gene regulatory elements

New virus-based approach for measuring variations in gene regulatory elements

18 Mar 2022
Scientists develop virus-blocking textile that effectively repulses SARS-CoV-2

Scientists develop virus-blocking textile that effectively repulses SARS-CoV-2

18 Mar 2022
Hypoxia-inducible factors and SARS-CoV-2 manifestations

Hypoxia-inducible factors and SARS-CoV-2 manifestations

18 Mar 2022
Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

18 Mar 2022
Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

18 Mar 2022
SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

18 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback